The Impact Of Neurologic Disease On The Urinary Tract An Issue Of Urologic Clinics

The Guest Editors have assembled expert authors to provide clinical reviews on the current knowledge about the impact of neurologic disease on the urinary tract. Specific articles are devoted to the following topics: The Cost of Care in Neurogenic Lower Urinary Tract Dysfunction; How to Measure Quality of Life Concerns in Patients with Neurogenic Lower Urinary tract Dysfunction; Long-term Complications of the Neurogenic Bladder; Surveillance Strategies for Patients with Neurogenic Bladder; Establishing a Multi-disciplinary Approach to the Management of Neurologic Disease affecting the Urinary Tract; Evaluation and Lifetime Management of the Urinary Tract in Patients with Myelomeningocele; Contemporary Treatment of Post-Stroke Lower Urinary Tract Dysfunction; Parkinson’s Disease and its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies; Management of the Neurogenic Bladder in Patients with Multiple Sclerosis; Identifying the High-Risk Neurogenic Bladder after Spinal cord Injury; Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction; Disease-specific Outcomes of Botulinum; Toxin Injections for Neurogenic Detrusor Overactivity; Surgical Management of Neurogenic Lower Urinary Tract Dysfunction; Tissue Engineering Strategies for Neurogenic Lower Urinary Tract Dysfunction; Mending Gaps in Knowledge: Collaboratives in Neurogenic Bladder Research. Readers will be able to employ this clinical information in the treatment and management of their neurologic patients.

The Guest Editors have assembled expert authors to provide clinical reviews on the current knowledge about the impact of neurologic disease on the urinary tract. Specific articles are devoted to the following topics: The Cost of Care in Neurogenic Lower Urinary Tract Dysfunction; How to Measure Quality of Life Concerns in Patients with Neurogenic Lower Urinary tract Dysfunction; Long-term Complications of the Neurogenic Bladder; Surveillance Strategies for Patients with Neurogenic Bladder; Establishing a Multi-disciplinary Approach to the Management of Neurologic Disease affecting the Urinary Tract; Evaluation and Lifetime Management of the Urinary Tract in Patients with Myelomeningocele; Contemporary Treatment of Post-Stroke Lower Urinary Tract Dysfunction; Parkinson's Disease and its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies; Management of the Neurogenic Bladder in Patients with Multiple Sclerosis; Identifying the High-Risk Neurogenic Bladder after Spinal cord Injury; Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction; Disease-specific Outcomes of Botulinum; Toxin Injections for Neurogenic Detrusor Overactivity; Surgical Management of Neurogenic Lower Urinary Tract Dysfunction; Tissue Engineering Strategies for Neurogenic Lower Urinary Tract Dysfunction; Mending Gaps in Knowledge: Collaboratives in Neurogenic Bladder Research. Readers will be able to employ this clinical information in the treatment and management of their neurologic patients.

In this issue of Urologic Clinics of North America, guest editor Dr. John T. Stoffel brings his considerable expertise to the topic of Updates in Neurourology. Top experts in the field provide important clinical updates to help you manage patients with a range of therapies for neurogenic bladder, including medical management, bladder augmentation, Botox therapy, and sacral neuromodulation. Other key articles address racial and economic disparities and the multidisciplinary team involved in care. Contains 14 relevant, practice-oriented topics covering urologic updates from various neurologic conditions; understanding physiology; tools of neurourologic care; and social factors regarding neurourologic care. Provides in-depth clinical reviews on neurourology, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

The Guest Editors have secured the top urologists to provide current clinical reviews on the latest advances in the management of small renal masses. Articles are devoted to the following topics: hereditary yndromes; trends in renal surgery; humor anatomic complexity; risk assessment; renal biopsy; active surveillance; ablation; surgical techniques; renal ischemia; lymph node dissection; complications; neoadjuvant targeted therapy for renal surgery; salvage surgery; and post-operative surveillance. Readers will come away with a succinct overview of the most clinically relevant articles and be able to immediately implement the clinical information in their practice.

Dr. Cookson has put together topics and authors that speak to current knowledge on urinary diversion. Top experts provide timely clinical reviews on the most relevant information to urologists performing this surgery. Articles are devoted to the following topics: Patient Selection and Counseling for Urinary Diversion; Perioperative Preparation and Nutritional Considerations; Male Neobladder; Female Neobladder; Continent Cutaneous Urinary Diversion; Conduit Urinary Diversion; Metabolic and Nutritional Complications of Urinary Diversion; Surgical Complications of Continent Diversion; Intracorporeal Urinary Diversion; Secondary Tumors after Urinary Diversion; Quality of Life in Urinary Diversion; Urinary Diversion in Renal Transplant Patients; Urinary Diversion in the Pediatric Patients; and Tissue Engineering and Conduit Substitution. Readers will leave with the current information they need to manage patients surgically and clinically.

Dr. Samir Taneja, Consulting Editor, is stepping into the Guest Editor role for this issue of Urologic Clinics devoted to Prostate Cancer. He has assembled top experts to address the latest advances in the diagnosis and treatment of prostate cancer. Articles are devoted to the following topics: Whom to Biopsy: Pre-Diagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators; How to Biopsy: Transperineal vs. Tranrectal, Saturation vs. Targeted: What’s the Evidence; Pre-Diagnostic Risk and Assessment with Imaging and Image-guided Biopsy; Whom to treat: Post-Diagnostic Risk Assessment with Gleason score, Risk Models, and Genomic Classifier; Strategies for Staging and Utilization of Imaging; Contemporary Active Surveillance: Candidate Selection, Follow-up Tools, and Expected Outcomes; Focal Ablation of Early Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome; Extent of Lymphadenectomy at Time of Prostatectomy: An Evidence-based Approach; How to Radiate the Prostate: Hypofractionation, Sterotactic Body Radiation Therapy, and Conventional Intensity-Modulated Radiotherapy; Managing Relapse after Surgical Therapy: Adjuvant vs. Salvage Therapy; Newly diagnosed Metastatic Prostate Cancer – Has the Paradigm Changed; Role of Local therapy in Oligometastatic Prostate Cancer: Should we Expect Cure; Approaching the High-Risk Patient; and Castration-Resistant Prostate Cancer: An Algorithmic Approach. Readers will come away with state-of-the-art information on strategies for diagnosing, treating, and managing prostate cancer.

The Editor has assembled top experts to write authoritative reviews on the latest advances in the diagnosis and treatment of penile, urethral, and scrotal cancers. The issue stresses contrasting approaches and includes articles devoted to the following topics: radiation in primary urethral cancers; the role of node dissection; role of HPV in penile pre-neoplastic and carcinogenesis; advances in penile-sparing surgical approaches in the management of primary penile tumors; minimally invasive approaches to evaluating inguinal nodes in penile cancer patients; multimodal therapy in the management of advanced penile cancer; management of urethral cancer recurrences; Preneoplastic and primary scrotal cancer; and Advances in surgical reconstructive techniques in the management of penile, urethral, and scrotal cancer. The state-of-the article clinical and surgical details in this issue will keep urologists and other healthcare professionals current on the clinical management of these cancers.

Dr. Holzbeierlein has created an issue devoted to the current knowledge and best practice of Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. Top expert authors have written clinical reviews on the following topics: Current Staging Strategies for Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma; Neoadjuvant Chemotherapy for MIBC and Upper Tract UCC; Bladder Preservation Therapy for MIBC; Pre-Operative and Intraoperative Optimization of the Cystectomy Patient; Robotic Cystectomy; Robotic Nephroureterectomy; Organ Sparing Cystectomy; Lymphadenectomy for MIBC and Upper Tract UCC; ERAS Pathways; Follow-up Management of Cystectomy Patients; Quality of Life after Cystectomy; Endoscopic Approaches to Upper Tract UCC; Adjuvant Therapy in MIBC and Upper Tract UCC; and Immunotherapy in MIBC and Upper Tract UCC. The urologist will have the clinical information he or she needs to treat these patients so as to optimize outcomes.